Chemomab Therapeutics Balance Sheet (2017-2025) | CMMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	58.18M	45.40M	37.74M	15.19M	13.83M	9.88M	10.82M	13.52M	20.77M	10.38M	9.16M	9.29M	4.67M	5.11M	6.60M	6.07M	8.34M	5.60M	6.97M	7.56M
Short-term Investments (Quarter)	0.02M	21.52M	26.52M		43.58M	41.84M	35.73M	0.08M	11.94M	0.07M	0.07M	0.08M	0.07M	0.07M	0.07M	0.08M	0.14M	0.15M	0.15M	2.80M
Cash & Current Investments (Quarter)	58.20M	66.92M	64.27M	15.19M	57.41M	51.72M	46.54M	13.60M	32.71M	10.46M	9.23M	9.37M	4.74M	5.18M	6.68M	6.15M	8.48M	5.74M	7.12M	10.37M
Receivables - Net (Quarter)
Receivables - Other (Quarter)								1.77M		1.04M	0.92M	1.04M	0.89M	0.65M	0.44M	1.70M	1.27M	1.10M	1.72M	3.06M
Receivables (Quarter)
Prepaid Assets (Quarter)	0.32M	1.92M	1.57M	1.53M	1.93M	3.11M	2.26M	1.77M	0.99M			1.04M				1.70M				3.06M
Current Assets (Quarter)	59.52M	68.83M	65.84M	62.69M	59.34M	54.83M	48.73M	41.74M	33.78M	27.70M	22.37M	20.90M	16.84M	13.46M	19.89M	16.04M	11.98M	10.61M	11.93M	13.43M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.15M	0.24M	0.23M	0.36M	0.36M	0.35M	0.38M	0.37M	0.35M	0.34M	0.32M	0.30M	0.29M	0.28M	0.26M	0.25M	0.24M	0.22M	0.19M	0.18M
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)	0.05M	0.05M	0.05M	0.91M	0.09M	0.82M	0.08M	0.73M	0.69M	0.65M	0.60M	0.56M	0.52M	0.47M	0.43M	0.39M	0.34M	0.30M	0.25M	0.21M
Non-Current Assets (Quarter)	0.60M	1.68M	1.60M	1.67M	1.62M	1.55M	1.49M	1.33M	1.24M	1.14M	1.05M	1.25M	1.17M	1.09M	1.00M	0.92M	0.84M	0.52M	0.44M	0.39M
Assets (Quarter)	60.12M	70.52M	67.44M	64.35M	60.96M	56.38M	50.22M	43.06M	35.01M	28.85M	23.42M	22.15M	18.01M	14.54M	20.90M	16.96M	12.82M	11.13M	12.37M	13.81M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.08M	0.47M	0.48M	1.34M	1.49M	1.43M	1.25M	1.69M	2.22M	2.35M	0.73M	0.52M	0.53M	1.11M	0.39M	0.63M	0.49M	0.38M	0.19M	0.48M
Payables (Quarter)	2.08M	0.47M	0.48M	1.34M	1.49M	1.43M	1.25M	1.69M	2.22M	2.35M	0.73M	0.52M	0.53M	1.11M	0.39M	0.63M	0.49M	0.38M	0.19M	0.48M
Accumulated Expenses (Quarter)	0.52M	0.98M	0.45M	0.65M	0.67M	1.71M	1.53M	1.56M	3.16M	2.50M	3.01M	3.42M	3.40M	2.55M	3.12M	0.93M	1.36M	0.67M	0.46M	0.34M
Other Accumulated Expenses (Quarter)
Current Leases (Quarter)	0.07M	0.07M	0.06M	0.11M	0.12M	0.13M	0.13M	0.12M	0.12M			0.08M				0.12M
Total Current Liabilities (Quarter)	4.63M	2.16M	1.63M	2.65M	3.52M	4.39M	5.48M	6.75M	7.00M	6.83M	5.37M	4.84M	4.40M	4.31M	4.35M	3.22M	2.25M	1.43M	1.14M	1.48M
Non-Current Liabilities
Pension (Quarter)
Operating Leases (Quarter)	0.33M	0.32M	0.30M	0.34M	0.20M	0.15M	0.12M	0.21M	0.06M	0.11M	0.10M	0.39M	0.11M	0.11M	0.11M	0.21M	0.11M
Total Non-Current Liabilities (Quarter)	0.33M	0.32M	0.30M	0.24M	0.20M	0.15M	0.12M	0.09M	0.06M	0.03M	0.01M	0.32M	0.28M	0.25M	0.23M	0.21M	0.18M
Total Liabilities (Quarter)	4.96M	2.48M	1.93M	2.89M	3.72M	4.54M	5.59M	6.84M	7.06M	6.86M	5.38M	5.15M	4.68M	4.56M	4.58M	3.43M	2.43M	1.43M	1.14M	1.48M
Shareholder's Equity
Common Equity (Quarter)	55.16M	68.04M	65.51M	61.47M	57.24M	51.84M	44.62M	36.22M	27.95M			17.00M				13.54M				12.33M
Shareholder's Equity (Quarter)	55.16M	68.04M	65.51M	61.47M	57.24M	51.84M	44.62M	36.22M	27.95M	21.99M	18.04M	17.00M	13.33M	9.98M	16.32M	13.54M	10.39M	9.70M	11.23M	12.33M
Liabilities and Shareholders Equity (Quarter)	60.12M	70.52M	67.44M	64.35M	60.96M	56.38M	50.22M	43.06M	35.01M	28.85M	23.42M	22.15M	18.01M	14.54M	20.90M	16.96M	12.82M	11.13M	12.37M	13.81M
Treasury Shares (Quarter)								-11.64M	11.64M											10.07M
Retained Earnings (Quarter)	-25.40M	-28.17M	-31.14M	-36.17M	-41.28M	-47.47M	-55.55M	-63.82M	-72.57M	-80.54M	-84.62M	-88.68M	-92.55M	-96.18M	-99.66M	-102.62M	-105.95M	-108.00M	-109.75M	-111.62M

Research Tools

Chemomab Therapeutics Balance Sheet (2017-2025) | CMMB

Create an account

Sign In

Reset Password